Gilead Sciences, Inc. (GILD) Tops Q4 EPS by 2c

February 4, 2013 4:07 PM EST
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q4 EPS of $0.50, $0.02 better than the analyst estimate of $0.48. Revenue for the quarter came in at $2.59 billion versus the consensus estimate of $2.43 billion.

For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment